Comparison of the prevalence of the metabolic syndrome by WHO, AHA/NHLBI, and IDF definitions in a German population with type 2 diabetes: The Diabetes in Germany (DIG) study

Hormone and Metabolic Research

Volumn 39, Issue 9, 2007, Pages 632-635

  Koehler, C ^a   Ott, P ^a   Benke, I ^a   Hanefeld, M ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Metabolic syndrome; Prevalence; Type 2 diabetes

Indexed keywords

ADULT; AGED; ANTHROPOMETRY; CANCER; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GERMANY; HUMAN; HYPERTENSION; MACROPROTEINURIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MORBIDITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; SEX RATIO; WORLD HEALTH ORGANIZATION;

ADULT; AGED; AGED, 80 AND OVER; AMERICAN HEART ASSOCIATION; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC TECHNIQUES, ENDOCRINE; FEMALE; GERMANY; HUMANS; INTERNATIONAL AGENCIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; NATIONAL INSTITUTES OF HEALTH (U.S.); PREVALENCE; UNITED STATES; WORLD HEALTH ORGANIZATION;

EID: 34848836707     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-985816     Document Type: Conference Paper

References (18)

1. Isomaa B, Almgren P, Tuomi T et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689
2. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Sahnen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-1077
3. The DECODE Study Group. Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women. Arch Intern Med 2004; 164: 1066-1076
4. Hanefeld M, Leonhardt W. Das metabolische Syndrom. Dtsch Ges Wesen 1981; 36: 545-551
5. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications. Report of WHO consultation, 1999
6. Executive summary of the Third Report of The National Cholesterol Education Program (NCEP). Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
7. Grundy SM, Cleeman JI, Daniels SR, Donato KA et al. Diagnosis and Management of the Metabolic Syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735-2752
8. International Diabetes Federation. Worldwide definition of the metabolic syndrome. Available at: http://www.idf.org/webdata/docs/IDF_Meta- syndrome_definition.pdf Accessed August 24, 2005
9. Guize L, Thomas F, Pannier B, Bean K, Jego B, Benetos A. All-cause mortality associated with specific combinations of the metabolic syndrome according to recent definitions. Diabetes Care 2007, in press
10. The DECODE Study Group, Qiao Q. Comparison of different definitions of the metabolic syndrome in relation to cardiovascular mortality in European men and women. Diabetologia 2006; 49: 2837-2846
11. The Metascreen Writing Committee. The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes. Diabetes Care 2006; 29: 2701-2707
12. Hanefeld M, Koehler C, Gallo S, Benke I, Ott P. Combinations versus single traits of the metabolic syndrome as risk factors for atherosclerotic vascular disease in type 2 diabetes: The Diabetes in Germany (DIG) Study. Cardiovac Diab 2007; 6: 13
13. Gimeno Orna JA, Lou Arnal LM, Molinero Herguedas E, Boned Julian B, Portilla Cordoba DP. Metabolic syndrome as a cardiovascular risk factor in patients with type 2 diabetes. Rev Esp Cardiol 2004; 57: 507-513
14. Costa LA, Canani LH, Lisboa HR, Tres GS, Gross JL. Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes. Diabet Med 2004; 21: 252-255
15. Bruno G, Merletti F, Biggeri A, Bargero G, Ferrero S et al. Metabolic syndrome as a predictor of all-cause and cardiovascular mortality in type 2 diabetes: the Casale Monferrato Study. Diabetes Care 2004; 27: 2689-2694
16. Marchesini G, Forlani G, Cerrelli F, Manini R, Natale S et al. WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med 2004; 21: 383-387
17. Ilanne-Parikka P, Eriksson JG, Lindstrom J, Hamalainen H, Keinanen-Kiukaanniemi S et al. Finnish Diabetes Prevention Study Group: Prevalence of the metabolic syndrome and its components: findings from a Finnish general population sample and the Diabetes Prevention Study cohort. Diabetes Care 2004; 27: 2135-2140
18. Alexander CM, Landsman PB, Teutsch SM, Haffner SM, Third National Health and Nutrition Examination Survey (NHANES III). NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-1214